Naltrexone And Bupropion
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1496
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| NB32 | 50.48% | 27.27% | n/r | n/r |
| Placebo | 17.11% | 7.02% | n/r | n/r |
Not shown
Every selected arm is drawn.